Patents matching “targeted”

US 8557290

Multifunction nanoconjugates for imaging applications and targeted treatment

Northwestern University · Granted Oct 15, 2013 · Expires Oct 10, 2033

US 8552167

Multifunctional aptamer-nucleic acid nanostructures for tumor-targeted killing

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 8, 2013 · Expires Oct 3, 2033

US 8535639

Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

US 8524500

Methods and compositions for targeted cleavage and recombination

Sangamo Biosciences, Inc. · Granted Sep 3, 2013 · Expires Aug 29, 2033

US 8518870

Compositions and methods for cancer treatment using targeted carbon nanotubes

The Board of Regents of the University of Oklahoma · Granted Aug 27, 2013 · Expires Aug 22, 2033

US 8492338

Targeted therapeutic proteins

BIOMARIN PHARMACEUTICAL INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

US 8492337

Targeted therapeutic proteins

BIOMARIN PHARMACEUTICAL INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

US 8389679

Targeted antimicrobial moieties

The Regents of the University of California · Granted Mar 5, 2013 · Expires Feb 28, 2033

US 8349810

Methods for targeted cleavage and recombination of CCR5

Sangamo Biosciences, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

US 8324368

GNAQ targeted dsRNA compositions and methods for inhibiting expression

Alnylam Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

US 8324181

Modulation of gene expression by oligomers targeted to chromosomal DNA

The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

US 8318700

Lung-targeted drugs

The Regents of the University of California · Granted Nov 27, 2012 · Expires Nov 22, 2032

US 8313772

Compositions for targeted delivery of siRNA

Arrowhead Madison, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

US 8252338

Synthetic LDL as targeted drug delivery vehicle

The Regents of the University of California · Granted Aug 28, 2012 · Expires Aug 23, 2032

US 8207114

Targeted therapeutic proteins

BIOMARIN PHARMACEUTICAL INC. · Granted Jun 26, 2012 · Expires Jun 21, 2032

US 8188096

Protein kinase targeted therapeutics

Northwestern University · Granted May 29, 2012 · Expires May 24, 2032

US 8143232

Gene fusion targeted therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 27, 2012 · Expires Mar 22, 2032

US 8110379

Targeted integration into the PPP1R12C locus

Sangamo Biosciences, Inc. · Granted Feb 7, 2012 · Expires Feb 2, 2032

US 8101745

Lung-targeted drugs

The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

US 8007804

Complement receptor 2 targeted complement modulators

The Regents of the University of Colorado · Granted Aug 30, 2011 · Expires Aug 25, 2031

US 7972854

Methods and compositions for targeted cleavage and recombination

Sangamo Biosciences, Inc. · Granted Jul 5, 2011 · Expires Jun 30, 2031

US 7919485

Protein kinase targeted therapeutics

Northwestern University · Granted Apr 5, 2011 · Expires Mar 31, 2031

US 7888121

Methods and compositions for targeted cleavage and recombination

Sangamo Biosciences, Inc. · Granted Feb 15, 2011 · Expires Feb 10, 2031

US 7846895

Selectively targeted antimicrobial peptides and the use thereof

The Regents of the University of California · Granted Dec 7, 2010 · Expires Dec 2, 2030